List view / Grid view
1 December 2014 | By Arthurian Life Sciences
Arthurian Life Sciences, the specialist fund management company led by Professor Sir Chris Evans, announced it has formed a partnership with one of the leading medtech firms in the US, Interrad Medical Inc...
1 December 2014 | By Treeway
Treeway B.V. is pleased to announce that the European Medicines Agency has granted orphan drug designation for TW001 for the treatment of ALS...
1 December 2014 | By Futura Medical
Futura Medical plc, the innovative healthcare company focused on advanced transdermal technology, is pleased to announce that it will shortly be making a submission to UK regulators for approval to begin a clinical study to assess the efficacy and safety of its three topical pain relief products, which have already…
28 November 2014 | By Public Health England
Almost two months since the launch of the seasonal flu vaccine campaign, the first monthly uptake figures show an encouraging start, but Public Health England (PHE) is urging all at risk people not to ‘put off’ getting the vaccination until flu is circulating more widely...
27 November 2014 | By ViiV Healthcare
Landmark number of grants awarded for 2015 as the Positive Action for Children Fund hits 5 year milestone...
27 November 2014 | By Public Health England
Recent reports of meningitis and septicaemia cases in students...
27 November 2014 | By Boehringer Ingelheim
Boehringer Ingelheim announced that the European Commission has granted EU marketing authorisation for Vargatef® (nintedanib*), valid for the 28 countries within the EU...
27 November 2014 | By Bristol-Myers Squibb
Bristol-Myers Squibb Company announced that the U.S. Food and Drug Administration has issued a Complete Response Letter regarding the New Drug Application for daclatasvir, an NS5A complex inhibitor, in combination with other agents for the treatment of hepatitis C...
27 November 2014 | By European Alcohol Policy Alliance
Today over 300 representatives from Health Ministries, the European Institutions, public health experts and concerned stakeholders have gathered in Brussels to call on the European Commission President Jean-Claude Juncker and his team to take actions to prevent and reduce the burden of alcohol on European societies...
26 November 2014 | By Apitope
Treatment for haemophilia A patients developing Factor VIII inhibitors...
26 November 2014 | By Janssen
Economic and societal value of Europe’s biopharmaceutical sector can only be sustained if risks to innovation are adequately rewarded, study concludes...
26 November 2014 | By SELECTBIO
SELECTBIO is organizing the 3rd Annual International QbD conference “QbD in Pharma Development World Congress 2015” with the theme "Emerging Challenges, Federal Issues & Possible Solutions" scheduled to be held on April 16-18, 2015 in Hotel Shivalik View, Chandigarh, India...
26 November 2014 | By Cardio3 BioSciences
Cardio3 BioSciences announces the appointment of its three Co-Principal Investigators for the CHART-2 study (Congestive Heart Failure cArdiopoietic Regenerative Therapy), authorized in the United States by the FDA in January, and anticipated to start by the end of 2014...
25 November 2014 | By Cobalt Light Systems
Cobalt Light Systems is pleased to announce that a major pharmaceutical company has gained regulatory approval to release products using Cobalt’s TRS100 instrument instead of by HPLC...
25 November 2014 | By Janssen
Janssen-Cilag International NV announced that the European Commission (EC) has approved the use of REZOLSTA® (darunavir/cobicistat) in combination with other antiretroviral (ARV) medicinal products for the treatment of human immunodeficiency virus-1 (HIV-1) infection in adults aged 18 years or older...
